Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seeing Makes the Difference: Augmented Reality in the OR.

IEEE pulse·2022
Same author

A Life Well Lived: In Memory of Máximo E. Valentinuzzi.

IEEE pulse·2022
Same author

Working Toward Diversity and Inclusion in Neural Engineering.

IEEE pulse·2021
Same author

Harnessing Another Tool for Treating Brain Cancer.

IEEE pulse·2021
Same author

Solving Unmet Needs With Innovative Pediatric Medical Devices.

IEEE pulse·2021
Same author

Testing PPE: Are DIY Masks a Viable Alternative to Address Shortages?

IEEE pulse·2020
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.7K

The RADxSM Tech Process: Accelerating Innovation for COVID-19 Testing.

Cynthia Weber

    IEEE Pulse
    |June 22, 2021
    PubMed
    Summary
    This summary is machine-generated.

    The National Institutes of Health launched the Rapid Acceleration of Diagnostics (RADx) initiative to speed up the development and implementation of COVID-19 diagnostic tests. RADx Tech specifically supports innovative point-of-care, home, and lab-based SARS-CoV-2 detection technologies.

    More Related Videos

    Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
    08:26

    Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

    Published on: June 23, 2022

    1.9K
    Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
    05:34

    Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

    Published on: September 8, 2023

    987

    Related Experiment Videos

    Last Updated: Nov 1, 2025

    Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
    11:11

    Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

    Published on: February 11, 2022

    4.7K
    Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
    08:26

    Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

    Published on: June 23, 2022

    1.9K
    Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
    05:34

    Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

    Published on: September 8, 2023

    987

    Area of Science:

    • Biomedical Engineering
    • Diagnostic Technology Development
    • Public Health Preparedness

    Background:

    • The COVID-19 pandemic highlighted the critical need for rapid and accurate diagnostic testing.
    • Existing grant review and funding processes were insufficient to meet the urgent demand for new diagnostic solutions.

    Purpose of the Study:

    • To describe the establishment and objectives of the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) initiative.
    • To outline the specific focus of the RADx Tech program on advancing SARS-CoV-2 diagnostic technologies.
    • To detail the role of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and its Point-of-Care Technology Research Network (POCTRN) in enabling this initiative.

    Main Methods:

    • Investment in diagnostic testing research and development.
    • Restructuring grant proposal review and funding processes for accelerated timelines.
    • Focusing on innovative point-of-care, home-based, and clinical laboratory diagnostic technologies.
    • Leveraging the infrastructure of the NIBIB Point-of-Care Technology Research Network (POCTRN).

    Main Results:

    • The RADx initiative was established to expedite the innovation, commercialization, and implementation of COVID-19 diagnostic technologies.
    • RADx Tech specifically targets the development, validation, and commercialization of SARS-CoV-2 detection tests.
    • The initiative facilitated a faster pathway for promising diagnostic technologies.

    Conclusions:

    • The RADx initiative successfully addressed the urgent need for advanced COVID-19 diagnostics.
    • RADx Tech plays a crucial role in bringing innovative SARS-CoV-2 testing solutions to various settings.
    • The program demonstrates a model for rapidly advancing critical medical technologies through strategic investment and streamlined processes.